Preclinical In-vivo Imaging Market - 2024-2031
Preclinical In-vivo Imaging Marketis is growing with a CAGR of 6.40% during the forecast period 2026-2035.
The Preclinical In-vivo Imaging Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Preclinical In-vivo Imaging Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Modality
Both primary and secondary data sources have been used in the global Preclinical In-vivo Imaging Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Preclinical In-vivo Imaging Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Preclinical In-vivo Imaging Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Modality
- Optical Imaging Systems *
- Bioluminescence/Fluorescence Imaging Systems
- Standalone Fluorescence Imaging Systems
- Optical + X-Ray/Optical + CT
- Preclinical Nuclear Imaging Systems
- Micro-PET Systems
- Micro-SPECT Systems
- Trimodality (SPECT/PET/CT) Systems
- Micro-MRI Systems
- Micro-Ultrasound Systems
- Micro-CT Systems
- Preclinical Photoacoustic Imaging Systems
- Preclinical Magnetic Particle Imaging (MPI) Systems
- Preclinical Optical Imaging Reagents *
- Bioluminescent Imaging Reagents
- Fluorescent Imaging Reagents
- Preclinical Nuclear Imaging Reagents
- Preclinical PET Tracers
- Preclinical SPECT Probes
- Preclinical MRI Contrast Agents
- Gadolinium-based Preclinical MRI Contrast Agents
- Iron-based Preclinical MRI Contrast Agents
- Manganese-based Preclinical MRI Contrast Agents
- Preclinical Ultrasound Contrast Agents
- Preclinical CT contrast agents
- Iodine-based Preclinical CT Contrast Agents
- Barium-based Preclinical CT Contrast Agents
- Gold Nanoparticles
- Gastrografin-based Preclinical CT Contrast Agents
- Research and development*
- Drug discovery
- Pharmaceutical companies*
- Biotechnology companies
- Research institutes
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Preclinical In-vivo Imaging Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Modality
3.2. Market Snippet by Reagent
3.3. Market Snippet by Application
3.4. Market Snippet by Distribution channel
4. DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of chronic diseases
4.1.1.2. The rising funding for preclinical research activities
4.1.2. Restraints
4.1.2.1. High installation and operational costs of preclinical in-vivo imaging modalities
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. BY MODALITY
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality type
6.1.2. Market Attractiveness Index, By Modality Segment
6.2. Optical Imaging Systems *
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.2.2.1.1. Bioluminescence/Fluorescence Imaging Systems
6.2.2.1.2. Standalone Fluorescence Imaging Systems
6.2.2.1.3. Optical + X-Ray/Optical + CT
6.3. Preclinical Nuclear Imaging Systems
6.3.1. Introduction
6.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.3.2.1.1. Micro-PET Systems
6.3.2.1.2. Micro-SPECT Systems
6.3.2.1.3. Trimodality (SPECT/PET/CT) Systems
6.4. Micro-MRI Systems
6.5. Micro-Ultrasound Systems
6.6. Micro-CT Systems
6.7. Preclinical Photoacoustic Imaging Systems
6.8. Preclinical Magnetic Particle Imaging (MPI) Systems
7. BY REAGENT
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent type
7.1.2. Market Attractiveness Index, By Reagent Segment
7.2. Preclinical Optical Imaging Reagents *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.2.2.1.1. Bioluminescent Imaging Reagents
7.2.2.1.2. Fluorescent Imaging Reagents
7.3. Preclinical Nuclear Imaging Reagents
7.3.1. Introduction
7.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.3.2.1.1. Preclinical PET Tracers
7.3.2.1.2. Preclinical SPECT Probes
7.4. Preclinical MRI Contrast Agents
7.4.1. Introduction
7.4.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.4.2.1.1. Gadolinium-based Preclinical MRI Contrast Agents
7.4.2.1.2. Iron-based Preclinical MRI Contrast Agents
7.4.2.1.3. Manganese-based Preclinical MRI Contrast Agents
7.5. Preclinical Ultrasound Contrast Agents
7.6. Preclinical CT contrast agents
7.6.1. Introduction
7.6.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.6.2.1.1. Iodine-based Preclinical CT Contrast Agents
7.6.2.1.2. Barium-based Preclinical CT Contrast Agents
7.6.2.1.3. Gold Nanoparticles
7.6.2.1.4. Gastrografin-based Preclinical CT Contrast Agents
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application Segment
8.2. Research and development*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
8.3. Drug discovery
9. BY DISTRIBUTION CHANNEL
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel Segment
9.1.2. Market Attractiveness Index, By Distribution channel Segment
9.2. Pharmaceutical companies*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
9.3. Biotechnology companies
9.4. Research institutes
9.5. Others
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. The U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. The U.K.
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia Pacific
10.6. The Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Bruker Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Siemens A.G.
12.3. TriFoil Imaging
12.4. PerkinElmer
12.5. VisualSonics Inc. (Fujifilm)
12.6. MILabs B.V.
12.7. Mediso Ltd.
12.8. Agilent Technologies
13. PREMIUM INSIGHTS
14. DATA M INTELLIGENCE
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Modality
3.2. Market Snippet by Reagent
3.3. Market Snippet by Application
3.4. Market Snippet by Distribution channel
4. DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of chronic diseases
4.1.1.2. The rising funding for preclinical research activities
4.1.2. Restraints
4.1.2.1. High installation and operational costs of preclinical in-vivo imaging modalities
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. BY MODALITY
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality type
6.1.2. Market Attractiveness Index, By Modality Segment
6.2. Optical Imaging Systems *
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.2.2.1.1. Bioluminescence/Fluorescence Imaging Systems
6.2.2.1.2. Standalone Fluorescence Imaging Systems
6.2.2.1.3. Optical + X-Ray/Optical + CT
6.3. Preclinical Nuclear Imaging Systems
6.3.1. Introduction
6.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.3.2.1.1. Micro-PET Systems
6.3.2.1.2. Micro-SPECT Systems
6.3.2.1.3. Trimodality (SPECT/PET/CT) Systems
6.4. Micro-MRI Systems
6.5. Micro-Ultrasound Systems
6.6. Micro-CT Systems
6.7. Preclinical Photoacoustic Imaging Systems
6.8. Preclinical Magnetic Particle Imaging (MPI) Systems
7. BY REAGENT
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent type
7.1.2. Market Attractiveness Index, By Reagent Segment
7.2. Preclinical Optical Imaging Reagents *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.2.2.1.1. Bioluminescent Imaging Reagents
7.2.2.1.2. Fluorescent Imaging Reagents
7.3. Preclinical Nuclear Imaging Reagents
7.3.1. Introduction
7.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.3.2.1.1. Preclinical PET Tracers
7.3.2.1.2. Preclinical SPECT Probes
7.4. Preclinical MRI Contrast Agents
7.4.1. Introduction
7.4.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.4.2.1.1. Gadolinium-based Preclinical MRI Contrast Agents
7.4.2.1.2. Iron-based Preclinical MRI Contrast Agents
7.4.2.1.3. Manganese-based Preclinical MRI Contrast Agents
7.5. Preclinical Ultrasound Contrast Agents
7.6. Preclinical CT contrast agents
7.6.1. Introduction
7.6.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.6.2.1.1. Iodine-based Preclinical CT Contrast Agents
7.6.2.1.2. Barium-based Preclinical CT Contrast Agents
7.6.2.1.3. Gold Nanoparticles
7.6.2.1.4. Gastrografin-based Preclinical CT Contrast Agents
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application Segment
8.2. Research and development*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
8.3. Drug discovery
9. BY DISTRIBUTION CHANNEL
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel Segment
9.1.2. Market Attractiveness Index, By Distribution channel Segment
9.2. Pharmaceutical companies*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
9.3. Biotechnology companies
9.4. Research institutes
9.5. Others
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. The U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. The U.K.
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia Pacific
10.6. The Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Bruker Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Siemens A.G.
12.3. TriFoil Imaging
12.4. PerkinElmer
12.5. VisualSonics Inc. (Fujifilm)
12.6. MILabs B.V.
12.7. Mediso Ltd.
12.8. Agilent Technologies
13. PREMIUM INSIGHTS
14. DATA M INTELLIGENCE
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us
